HOMEVULNERABILITIESCVE-2017-14111
HIGH

CVE-2017-14111

CWE-522Published: November 17, 2017· Updated: Jun 17, 2026

7.2
CVSS v3.1

Official Description

The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and earlier records domain authentication credentials, which if accessed allows an attacker to use credentials to access the application, or other user entitlements.

NVD Source

Technical Analysis

CVE-2017-14111 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

Exploitation requires high privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 7.2.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.High
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityHigh
AvailabilityHigh
CVSS:3.0/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

Affected Vendors & Products

philips2 product(s)
intellispace cardiovascularxcelera
Source: NVD CPE · 2 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

ADVISORYhttp://www.securityfocus.com/bid/101850
ADVISORYhttps://ics-cert.us-cert.gov/advisories/ICSMA-17-318-01
ADVISORYhttps://www.usa.philips.com/healthcare/about/customer-support/product-security
ADVISORYhttp://www.securityfocus.com/bid/101850
ADVISORYhttps://ics-cert.us-cert.gov/advisories/ICSMA-17-318-01
ADVISORYhttps://www.usa.philips.com/healthcare/about/customer-support/product-security

All References (6)

→
http://www.securityfocus.com/bid/101850Third Party Advisory · VDB Entry
→
https://ics-cert.us-cert.gov/advisories/ICSMA-17-318-01Issue Tracking · Third Party Advisory · US Government Resource
→
https://www.usa.philips.com/healthcare/about/customer-support/product-securityIssue Tracking · Mitigation · Vendor Advisory
→
http://www.securityfocus.com/bid/101850Third Party Advisory · VDB Entry
→
https://ics-cert.us-cert.gov/advisories/ICSMA-17-318-01Issue Tracking · Third Party Advisory · US Government Resource
→
https://www.usa.philips.com/healthcare/about/customer-support/product-securityIssue Tracking · Mitigation · Vendor Advisory

Quick Facts

CVE IDCVE-2017-14111
CVSS Score7.2 / 10
SeverityHIGH
WeaknessCWE-522
CISA KEVNo
Affected1 vendor(s)
PublishedNov 17, 2017

Related CVEs (CWE-522)

CVE-2024-12799
10.0
CVE-2026-29128
10.0
CVE-2021-36783
9.9
CVE-2026-56843
9.9
CVE-2019-1384
9.9
CVE-2025-0867
9.9

Recommended Actions

  • →Apply vendor patches immediately
  • →Monitor CVE-2017-14111 in threat intel feeds
  • →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.
← All Vulnerabilities·Search for CVE-2017-14111·NVD